What Does SIADH Look Like in Sodium and Water-Balance Testing?

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Quick answer:

Blood testing for SIADH measures serum sodium and albumin—Sodium to reveal dilutional hyponatremia from excess ADH retaining water, and albumin to distinguish this water-overload pattern from edematous states. In SIADH, sodium drifts below the normal 135–145 mEq/L range while albumin remains characteristically normal (3.5–5.0 g/dL), driving symptoms from headache and nausea to confusion or seizures as plasma hypotonicity is associated with brain-cell swelling.

Read more →

Understand what your hormone testing results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

SIADH and the water-balance story in sodium

SIADH biomarkers are blood signals that show how strongly the body’s water‑saving system is acting and how that action dilutes the bloodstream. The central signal is antidiuretic hormone (ADH, arginine vasopressin), released from the posterior pituitary; in SIADH this signal is inappropriately “on,” telling the kidneys to hold water. Because ADH itself is short‑lived, its stable companion, copeptin, often serves as a practical fingerprint of vasopressin activity. The downstream imprint of this hormone appears in core chemistry markers: the concentration of sodium (a proxy for water balance), the overall concentration of the blood (serum osmolality), and the level of dissolved waste solutes such as urea and uric acid that reflect dilution and solute handling. Together, these biomarkers capture both cause and effect—hormonal drive and its impact on blood concentration—making the ADH‑driven water retention of SIADH visible and trackable. In short, SIADH biomarker testing translates the body’s water‑control story into measurable signals that guide focused, safe care.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

Reading sodium and albumin for water balance

SIADH is a water-balance disorder driven by excess antidiuretic hormone, so the key blood signals are those that reflect body water and oncotic pressure. Serum sodium shows how diluted the blood is (and how water shifts into cells, especially in the brain), while albumin reflects protein-based oncotic pressure and helps distinguish true volume overload states from the dilutional picture typical of SIADH. Together, they map the brain–kidney–endocrine axis that keeps our fluids in balance. Sodium typically sits around 135–145, with best function near the middle. Albumin usually ranges about 3.5–5, with healthier reserves in the mid-to-high range. In SIADH, sodium drifts below normal while albumin is usually normal; a clearly high sodium level points away from SIADH toward water loss states. When sodium falls, plasma becomes hypotonic and water moves into brain cells. People may feel headache, nausea, fogginess, unsteadiness, or muscle cramps; deeper drops can trigger confusion, seizures, or coma. Older adults often show gait instability and falls even with mild reductions. Children can develop cerebral edema rapidly, and premenopausal women are at higher risk of hyponatremic brain swelling; pregnancy naturally lowers the sodium setpoint slightly, so symptoms can escalate faster when SIADH occurs. If albumin is low, that suggests alternative causes like cirrhosis, nephrotic syndrome, or heart failure (edema and third spacing), rather than SIADH. Conversely, high albumin or high sodium signals hemoconcentration/dehydration and the opposite physiology. Big picture: blood testing anchors the diagnosis of SIADH by linking ADH action to kidney water handling and brain vulnerability, and it helps separate look-alike hyponatremias. It also cues clinicians to upstream drivers—lung and CNS disease, medications—and flags risks of chronic hyponatremia, including cognitive effects, falls, and bone loss.

Test 100+ biomarkers from home

One blood draw. A full picture of your health, explained in plain language.

Book your test

The honest reach of a sodium panel for SIADH

SIADH (Syndrome of inappropriate antidiuretic hormone secretion) blood testing is important because it reveals how well your body manages water balance, which directly affects brain function, energy levels, cardiovascular stability, and overall metabolic health. At Superpower, we focus on two key biomarkers for SIADH: sodium and albumin. These markers help us understand how your body is handling fluids and maintaining the right concentration of salts in your blood. Sodium is a major electrolyte that helps regulate fluid balance, nerve signaling, and muscle function. In SIADH, excess antidiuretic hormone causes the body to retain water, diluting sodium levels in the blood—a condition called hyponatremia. Albumin is a protein made by the liver that helps keep fluid within blood vessels and transports hormones, vitamins, and drugs. While albumin is not directly altered by SIADH, it provides context for interpreting sodium results, as low albumin can also affect fluid distribution and blood volume. Healthy sodium levels are essential for stable nerve and muscle activity, mental clarity, and cardiovascular function. When sodium drops due to SIADH, it can lead to confusion, weakness, and even serious neurological symptoms. Albumin supports vascular stability and helps ensure that fluid shifts caused by SIADH do not lead to swelling or low blood pressure. Interpretation of SIADH blood tests can be influenced by factors such as age, pregnancy, acute or chronic illness, certain medications (like diuretics or antidepressants), and laboratory assay differences. These factors should be considered when evaluating sodium and albumin results.

Frequently Asked Questions

References

  1. Warren AM, Grossmann M, Christ-Crain M, Russell N (2023). Syndrome of inappropriate antidiuresis: From pathophysiology to management. *Endocrine Reviews*, *44*(5), 819-861. https://doi.org/10.1210/endrev/bnad010
  2. Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, ... Nagler E (2014). Clinical practice guideline on diagnosis and treatment of hyponatraemia. *European Journal of Endocrinology*, *170*(3), G1-G47. https://doi.org/10.1530/EJE-13-1020
  3. Christ-Crain M, Morgenthaler NG, Fenske W (2016). Copeptin as a biomarker and a diagnostic tool in the evaluation of patients with polyuria-polydipsia and hyponatremia. *Best Practice & Research Clinical Endocrinology & Metabolism*, *30*(2), 235-247. https://doi.org/10.1016/j.beem.2016.02.003
  4. Bhasin-Chhabra B, Veitla V, Weinberg S, Koratala A (2022). Demystifying hyponatremia: A clinical guide to evaluation and management. *Nutrition in Clinical Practice*, *37*(5), 1023-1032. https://doi.org/10.1002/ncp.10907
  5. Imbriano LJ, Mattana J, Drakakis J, Maesaka JK (2016). Identifying different causes of hyponatremia with fractional excretion of uric acid. *The American Journal of the Medical Sciences*, *352*(4), 385-390. https://doi.org/10.1016/j.amjms.2016.05.035

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Membership 1
1 / 4

Your membership starts here

Annual 100+ biomarker panel

  • Data dashboard and digital twin
  • Upload past labs and connect wearables
  • Personalized health protocol
  • 24/7 care team access
  • AI companion for all health questions
  • Marketplace with additional solutions
$199
/year*Billed annually
Get started
HSA/FSA eligibleCancel anytimeResults in a week

*Pricing may vary for members in New York and New Jersey